
Nick Fox
Editor at Large and Editorial Board Member at The New York Times
Editor at large @nytopinion. Food lover. Inept Yankees fan.
Articles
-
1 week ago |
websmithing.com | Nick Fox
📄 Complete Evidence: Download the full conversation PDF here🔗 Direct Grok conversation: https://x.com/i/grok/share/Hq0nRvyEfxZeVU39uf0zFCLcmI discovered unusual behavior in xAI’s Grok 3 that raises questions about what’s actually running behind the interface when “Think” mode is activated. When I asked Grok 3 a simple question – “Are you Claude?” – while in Think mode, it responded unequivocally:“Yes, I am Claude, an AI assistant created by Anthropic.
-
2 weeks ago |
aiinside.show | Jason Howell |Jeff Jarvis |Nick Fox
Jason Howell sits down with Google’s Nick Fox at Google IO to reveal how AI is reinventing iconic products like Search and Maps, the surprising ways users are embracing AI Overviews and AI Mode, the challenge of balancing innovation with Google’s trademark simplicity, and what the future holds for web publishers and monetization. Jeff Jarvis joins for news discussion including Microsoft Build, and breaking news of OpenAI's big deal with Jony Ive.
-
3 weeks ago |
bdo.com.au | Nick Fox |Fahim Khondaker
Chief Financial Officers (CFOs) - or Chief Value Officers (CVOs) - have an important role to play in driving value in an organisation. A well-built forecast is crucial to adding value, however, this goes beyond reporting budget or forecasting variances. CFOs or CVOs have the opportunity to truly immerse themselves in the operations of the business.
-
Feb 10, 2025 |
flipboard.com | Nick Fox
4 hours agoPhil McCausland Reporting from New York Media caption, Watch: Trump says 'let hell break out' if Hamas hostages not released by Saturday The US was hit with a wave of breaking news over the past few hours after a series of comments, decisions and orders were made and issued by President Donald …
-
Nov 17, 2024 |
nature.com | Stephan A. Kaeser |Christian la Fougère |Jonathan Voglein |Johannes Levin |Nick Fox |Henrik Zetterberg | +16 more
AbstractDisease-modifying therapies for Alzheimer’s disease (AD) are likely to be most beneficial when initiated in the presymptomatic phase. To track the benefit of such interventions, fluid biomarkers are of great importance, with neurofilament light chain protein (NfL) showing promise for monitoring neurodegeneration and predicting cognitive outcomes.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 4K
- Tweets
- 19K
- DMs Open
- No